Search Results - "Kaplow, June M"
-
1
CSF amyloid lowering in human volunteers after 14 days’ oral administration of the novel BACE1 inhibitor E2609
Published in Alzheimer's & dementia (2013)Get full text
Journal Article -
2
-
3
Clinical study of E2609, a novel BACE1 inhibitor, demonstrates target engagement and inhibition of BACE1 activity in CSF
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article -
4
First-in-human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta-amyloid levels after single dosing
Published in Alzheimer's & dementia (01-07-2012)Get full text
Journal Article -
5
INITIAL LEARNINGS FROM SCREENING STRATEGIES IN THE BAN 2401-G000-201 TRIAL: AN EARLY ALZHEIMER'S DISEASE STUDY
Published in Alzheimer's & dementia (01-07-2014)Get full text
Journal Article -
6
-
7
Pharmacology of BAN2401: A monoclonal antibody selective for beta-amyloid protofibrils
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article -
8
A first-in-human study of BAN2401, a novel monoclonal antibody against beta-amyloid protofibrils
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article -
9
-
10
A multimodal imaging study of mAb158, a murine monoclonal antibody with high selectivity for amyloid protofibrils, in Tg2576 mice
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article -
11
Monocyte chemoattractant protein-2 is a potent agonist of CCR2B
Published in Journal of leukocyte biology (01-12-1997)“…The binding and functional activity of the CC chemokines monocyte chemoattractant protein‐1 (MCP‐1), MCP‐2, and MCP‐3 have been characterized using Chinese…”
Get full text
Journal Article -
12
cDNA clones reveal differences between human glial and endothelial cell platelet-derived growth factor A-chains
Published in Nature (London) (13-08-1987)“…Human platelet-derived growth factor (PDGF) is a potent mitogenic polypeptide which is believed to be a heterodimer of A- and B-chains stabilized by interchain…”
Get full text
Journal Article -
13
-
14
P4‐181: INITIAL LEARNINGS FROM SCREENING STRATEGIES IN THE BAN 2401‐G000‐201 TRIAL: AN EARLY ALZHEIMER'S DISEASE STUDY
Published in Alzheimer's & dementia (01-07-2014)Get full text
Journal Article -
15
-
16
P4–411: Clinical study of E2609, a novel BACE1 inhibitor, demonstrates target engagement and inhibition of BACE1 activity in CSF
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article -
17
S4‐04‐01: CSF amyloid lowering in human volunteers after 14 days’ oral administration of the novel BACE1 inhibitor E2609
Published in Alzheimer's & dementia (01-07-2012)Get full text
Journal Article -
18
-
19
P4–286: Pharmacology of BAN2401: A monoclonal antibody selective for beta‐amyloid protofibrils
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article -
20
O4–05–01: A first‐in‐human study of BAN2401, a novel monoclonal antibody against beta‐amyloid protofibrils
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article